Result Summary for CNAF3016
| Protocol ID: | CNAF3016 |
| Clinical Study ID: | CNAF3016-MULTISUD |
| Official Title: | A Pilot Study to assess the Efficacy and Safety of a quadritherapy with Combivir, Abacavir, Nelfinavir switching from week 16 to (TZV), Nelfinavir for Antiretroviral Therapy in HIV-infected Naive Subjects with a viral load > 50 000 copies/mL |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | abacavir/lamivudine/zidovudine |
| Trade/Product Name: | trizivir;trizivir |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
